"Pituitary Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
Descriptor ID |
D010911
|
MeSH Number(s) |
C04.588.322.609 C04.588.614.250.195.885.500.600 C10.228.140.211.885.500.600 C10.228.140.617.477.600 C10.228.140.617.738.675 C10.551.240.250.700.500.500 C19.344.609 C19.700.734
|
Concept/Terms |
Pituitary Neoplasms- Pituitary Neoplasms
- Neoplasm, Pituitary
- Neoplasms, Pituitary
- Pituitary Neoplasm
- Pituitary Tumors
- Pituitary Tumor
- Tumor, Pituitary
- Tumors, Pituitary
Pituitary Adenoma- Pituitary Adenoma
- Adenoma, Pituitary
- Adenomas, Pituitary
- Pituitary Adenomas
Pituitary Carcinoma- Pituitary Carcinoma
- Carcinoma, Pituitary
- Carcinomas, Pituitary
- Pituitary Carcinomas
- Cancer of the Pituitary
- Pituitary Cancer
- Cancer, Pituitary
- Cancers, Pituitary
- Cancer of Pituitary
- Pituitary Cancers
|
Below are MeSH descriptors whose meaning is more general than "Pituitary Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pituitary Neoplasms".
This graph shows the total number of publications written about "Pituitary Neoplasms" by people in this website by year, and whether "Pituitary Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 1 | 1 | 2 |
2001 | 1 | 1 | 2 |
2002 | 2 | 0 | 2 |
2004 | 0 | 1 | 1 |
2005 | 2 | 0 | 2 |
2007 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 2 | 1 | 3 |
2015 | 2 | 0 | 2 |
2016 | 2 | 0 | 2 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pituitary Neoplasms" by people in Profiles.
-
Utility of intraoperative ultrasonography for resection of pituitary adenomas: a comparative retrospective study. Acta Neurochir (Wien). 2021 06; 163(6):1725-1734.
-
Supraorbital Craniotomy for Sellar Solitary Fibrous Tumor: Operative Technique and Literature Review. World Neurosurg. 2020 09; 141:395-401.
-
Endonasal Endoscopic Surgery for Pediatric Sellar and Suprasellar Lesions: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2020 08; 163(2):284-292.
-
Sinonasal quality-of-life outcomes after endoscopic endonasal skull base surgery. Int Forum Allergy Rhinol. 2019 10; 9(10):1105-1118.
-
MRI Findings of Suprasellar Germ Cell Tumors in Two Dogs. J Am Anim Hosp Assoc. 2018 May/Jun; 54(3):167-172.
-
Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage. Semin Ophthalmol. 2018; 33(4):581-588.
-
Factors impacting cerebrospinal fluid leak rates in endoscopic sellar surgery. Int Forum Allergy Rhinol. 2016 11; 6(11):1117-1125.
-
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21.
-
Predictors of 30-day morbidity and mortality in transnasal microscopic pituitary tumor excision. Int Forum Allergy Rhinol. 2016 Feb; 6(2):206-13.
-
Multi-institutional study of risk factors for perioperative morbidity following transnasal endoscopic pituitary adenoma surgery. Int Forum Allergy Rhinol. 2016 Jan; 6(1):101-7.